Table: Modalis Therapeutics -Q1 group results

Modalis Therapeutics

08/05/2024 08:00

May 8 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Mar 31, 2024        Mar 31, 2023     Dec 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
                                    (-100.0 pct)                  
  Operating     loss 490 mln        loss 514 mln                  
  Recurring     loss 457 mln        loss 509 mln                  
  Net           loss 457 mln        loss 532 mln                  
  EPS          loss 13.57 yen      loss 17.86 yen                 
  Ann Div                                NIL              NIL     
  -Q2 div                                NIL              NIL     
  -Q4 div                                NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T